针对蛋白质氨酸甲基转移酶5 (PRMT5) 的药物发现:更新
Zhouyang Gu1, Weizheng Kong1, Xing Liu1
1Department of Medicinal Chemistry, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
Bioorganic & medicinal chemistry
|May 24, 2025
概括
蛋白质氨酸甲基转移酶5 (PRMT5) 对于基因调节至关重要,并且与癌症有关. 开发PRMT5抑制剂为各种疾病,特别是恶性瘤提供了有前途的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 蛋白质氨酸甲基转移酶5 (PRMT5) 催化了影响基因表达,细胞分化和染色质结构的关键甲基化反应.
- 异常的PRMT5表达与各种疾病的发展和进展密切相关,特别是恶性瘤.
研究的目的:
- 提供PRMT5的全面概述,包括其结构,生物功能,调节机制和癌症中的作用.
- 审查针对PRMT5的药物发现策略的最新进展,重点关注抑制剂和降解剂.
主要方法:
- 文献审查和对PRMT5.5现有研究的分析.
- 综合了关于PRMT5的结构功能关系及其参与瘤发生的信息.
- 讨论针对PRMT5.5的当前和新兴治疗策略.
主要成果:
- 详细介绍了PRMT5在细胞过程中的多方面的作用,强调了其在基础研究之外的意义.
- 失调的PRMT5与多种癌症类型之间的关联得到了加强.
- 总结了开发针对PRMT5的小分子抑制剂和降解剂的近期进展.
结论:
- 向PRMT5代表了癌症治疗的可行治疗途径.
- 对PRMT5抑制剂和降解剂的进一步研究为新型抗癌疗法提供了重大潜力.
- 解决PRMT5向药物发现的挑战和探索未来方向对于临床翻译至关重要.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K